Clinical Trial Update: Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating valproate in combination with etoposide for patients with neuroectodermal tumors and brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Neuroectodermal Tumor

Drugs mentioned

• Etoposide (Etoposide)
• Valproate (valproate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neuroectodermal Tumor, Brain Metastases | Phase 1 | Status: COMPLETED